Health · Medical Research · 7 hrs ago
Mount Sinai receives $3.3 million grant to test hypertension care in rural Ghana
Mount Sinai researchers and Ghanaian partners received a $3.3 million grant to test community-based hypertension care in rural Ghana.
The project aims to bring high blood pressure treatment closer to people who live far from health centers.
In a 90-day pilot with 37 people, 86 percent reached normal blood pressure with help from community nurses and health workers.
The team will now study 504 adults with high blood pressure across 36 communities in Northern Ghana.
Researchers will compare care delivered through an existing public health program with treatment at clinics that can be hard to reach.
The randomized trial is due to start in fall 2027 and run for three years.
The team will also assess costs and consult communities and policymakers, with results intended to help inform national policy.
Mount Sinai researchers received a $3.3 million, five-year grant to test community-based hypertension care in rural Ghana.
The grant comes from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
The research team will test whether care delivered through an existing public primary health care program matches or improves on clinic-based care.
A randomized clinical trial will involve 504 adults in 36 communities across Northern Ghana.
The trial is due to start in fall 2027 and run for three years.
- Who
- Researchers at the Icahn School of Medicine at Mount Sinai and the Navrongo Health Research Centre will lead the study.
- What
- They will test a community-based care model for high blood pressure.
- When
- The trial is due to start in fall 2027 and run for three years.
- Where
- 36 communities across Northern Ghana.
- Why
- The study will assess whether care delivered in communities can produce outcomes as good as or better than clinic-based care, which can be far away and hard to access.
This story does not have two clearly opposing sides.
In a 90-day pilot in rural Ghana, 86 percent of 37 participants with hypertension achieved normal blood pressure.
The randomized clinical trial is due to begin in 36 communities across Northern Ghana.
The trial is scheduled to run for three years.
- Grant
- $3.3 million over five years
- Funder
- National Heart, Lung, and Blood Institute
- Trial participants
- 504 adults with high blood pressure
- Study sites
- 36 communities across Northern Ghana
- Pilot result
- 86 percent of 37 participants achieved normal blood pressure in a 90-day trial
What people are saying
My Ghanaian colleagues and I believe that primary care for chronic diseases can be brought out of the clinic, to people's doorsteps, where the care will be less costly and more impactful because it will prevent and control these diseases early.
This funding will make it possible to test that model, potentially revolutionizing the way hypertension care is delivered, not only in Ghana, but in communities globally.